The multicenter clinical trial with 92 patients that confirms the safety and effectiveness of the medical device MOWOOT to treat patients with constipation of different origin has been recently published in the prestigious journal ‘Clinical and Translational Gastroenterology’ ‘ with the title “Safety and Efficacy of Intermittent Colonic Exoperistalsis device to treat Chronic Constipation”. The … Continued
Cecilia Jané, nurse of the ‘Servei de Medicina i Rehabilitació’ of Althaia (Xarxa assistèncial Universitària de Manresa) participated in the IV International Congress of Physiotherapy in Pelvi-perineology (SEFIP) , held in Barcelona from October 24 to 26, to present the preliminary results of the study on the efficacy of MOWOOT, the non-pharmacological and non-invasive solution to treat chronic constipation. The study, still ongoing, is the result of a … Continued
The CSO of usMIMA, Immaculada Herrero, participated in the 12th Congress of the European Union Geriatric Medicine Society, held in Lisbon from October 5 to 7, to present the results of a clinical study on the effectiveness of MOWOOT, a non-drug and non-invasive solution for chronic constipation. Under the motto “Discovering new paths in … Continued
usMIMA, the team that developed the medical device MOWOOT, a non-drug and non-invasive solution to chronic constipation, signed a collaboration agreement with Biocat and Institut Guttmann. MOWOOT was developed after being inspired by a two-month stay at the Neurorehabilitation Centre Institut Guttmann during Biocat’s flagship program Design Health Barcelona. Ever since then the two institutions … Continued
After several months of work, preparation and dedication, usMIMA S.L., the company that developed MOWOOT, the non-pharmacological and non-invasive solution for constipation, has passed the certification audits for Quality Management Systems according to ISO 13485. This milestone adds to the recent achievement of CE certification as a class IIa medical device for MOWOOT, obtained last … Continued
Since the beginning of September this year MOWOOT has an office in London, UK. No, you did not read wrong. MOWOOT has been accepted to the MassChallenge accelerator UK and will have an office space in London during 3 months, which will be dedicated to learning and preparing the internationalization of the Spanish Medtech company. … Continued
Since last August, MOWOOT, the non-invasive, non-pharmacological solution to constipation without adverse effects, has CE certification as a Class IIa medical device. The CE marking guarantees that the equipment marketed complies with the essential requirements of the mandatory legislation. These requirements include tests for electrical safety, electromagnetic compatibility and usability, among other factors. The prestigious … Continued
The MOWOOT medical device – a non drug, non invasive solution for chronic constipation – was created by the usMIMA startup which was originated in the Moebio’s dHEALTH BCN program, a disruptive initiative for talent development driven by Biocat and inspired by Stanford Biodesign. The usMIMA project MOWOOT, winner of the Bio-Entrepreneur XXI 2014 Award, … Continued
usMIMA has been selected finalist in the Biotechnology and Health category of the Everis award 2015 of Fundación everis! The participation has been increased reaching over 400 international projects evaluated for the 2015 edition. In October the results and final classification for the award will be published. This article presents all the finalists and their … Continued
On Tuesday 9th of September Biocat organized the first European BioMedical Investors Day (EBID). The event took place at CCCB in Barcelona where 13 startups, from all over the world, had to present their projects to international investors in a 4 minutes pitch. In the picture above we can see Markus, one of usMIMA’s founders, … Continued